Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

552.32 +1.78 (+0.32%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 25, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,339,574
Open 550.10
Bid (Size) 547.00 (1)
Ask (Size) 556.41 (8)
Prev. Close 550.54
Today's Range 548.94 - 552.37
52wk Range 302.14 - 601.84
Shares Outstanding N/A
Dividend Yield 0.62%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Eli Lilly Unusual Options Activity For September 25
Via Benzinga
3 Artificial Intelligence (AI) Stocks That Could Soar More Than Nvidia, According to Wall Street
None of these stocks have outperformed Nvidia so far this year. But the next 12 months could be a different story. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence

Performance

YTD
+51.32%
+51.32%
1 Month
-0.24%
-0.24%
3 Month
+21.99%
+21.99%
6 Month
+65.07%
+65.07%
1 Year
+79.62%
+79.62%

More News

Read More
3 Magnificent Growth Stocks to Buy Right Now
Via The Motley Fool
David vs. Goliath: 3 Stocks Poised to Challenge the ‘Magnificent 7′
Via InvestorPlace
Immunomics Stocks: 3 Ways to Play This Massive AI-Biotech Megatrend
Via InvestorPlace
Peering Into Eli Lilly's Recent Short Interest
Via Benzinga
Eli Lilly Unusual Options Activity
Via Benzinga
1 Growth Stock That Could Turn $1,000 Into $2,500 by 2030
Via The Motley Fool
Here's How Much You Would Have Made Owning Eli Lilly Stock In The Last 15 Years
Via Benzinga
'Stocks In Monopolistic Bull Market': Wall Street Analyst Contemplates A Bright Future For Next Phase
Via Benzinga
Are Wall Street Analysts Wrong About Eli Lilly Stock?
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
The 7 Most Hated Stocks by Institutional Traders
Via InvestorPlace
On the Road to Halving Cancer: The 2023 Biotech Advancements Igniting Hope
Via FinancialNewsMedia
Elon Musk-Backed Neuralink Starts Participant Enrollment For Paralysis, Eli Lilly Cracks Down on Counterfeit Weight Loss Drugs, Meta Looks to Capitalize on India's In-App Payment Surge: Today's Top Stories
Via Benzinga
Eli Lilly Cracks Down on Counterfeit Mounjaro Wight Loss and Diabetes Drugs, Sues Lawsuit Against Clinics
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Demand for Abuse Deterrent Formulation Technology Skyrocketing as Opiate Abuse is on the Rise
Via FinancialNewsMedia
Topics Death Intellectual Property
Exposures Death Intellectual Property
Flee to Healthcare Stocks if Recession Rears its Head?
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
3 Healthcare Stocks That Turned $100,000 Into $1 Million in 10 Years
Via The Motley Fool
Could Ely Lilly Be the Best Pharma Stock to Own Now and Forever?
Via MarketBeat
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Can These 3 Healthcare Dividend Stocks Deliver Income Growth?
Via MarketBeat
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 (Bad) Reasons to Avoid or Sell Novo Nordisk Stock
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.